冠状动脉介入治疗-话题@MedSci

#冠状动脉介入治疗#

58篇内容 | 1074人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1648970, encodeId=f47d16489e0c3, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Cardiovasc Diabetol：甘油三酯-葡萄糖指数和剩余SYNTAX评分在预测接受经皮冠状动脉介入治疗的2型糖尿病患者中期主要心脏不良事件中的协同作用, objectType=article, longId=732999, objectId=5892e3299934, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5892e3299934, replyNumber=0, likeNumber=36, createdTime=2023-04-30, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5892e3299934, moduleTitle=Cardiovasc Diabetol：甘油三酯-葡萄糖指数和剩余SYNTAX评分在预测接受经皮冠状动脉介入治疗的2型糖尿病患者中期主要心脏不良事件中的协同作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5892e3299934)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648972, encodeId=4f7f16489e22d, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良, objectType=article, longId=739206, objectId=df2ee39206bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2ee39206bd, replyNumber=0, likeNumber=34, createdTime=2022-11-12, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2ee39206bd, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2ee39206bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648969, encodeId=30341648969c9, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Heart：血小板计数对经皮冠状动脉介入治疗患者的意义, objectType=article, longId=728876, objectId=416fe2887623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=416fe2887623, replyNumber=0, likeNumber=38, createdTime=2022-11-02, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=416fe2887623, moduleTitle=Heart：血小板计数对经皮冠状动脉介入治疗患者的意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=416fe2887623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648968, encodeId=be9d164896890, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病病患者高纤维蛋白原/白蛋白比与经皮冠状动脉介入治疗患者预后不良相关, objectType=article, longId=724356, objectId=3192e24356b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3192e24356b3, replyNumber=0, likeNumber=38, createdTime=2022-05-31, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3192e24356b3, moduleTitle=Cardiovasc Diabetol：2型糖尿病病患者高纤维蛋白原/白蛋白比与经皮冠状动脉介入治疗患者预后不良相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3192e24356b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648971, encodeId=203216489e1f4, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=JACC：经皮冠状动脉介入治疗术后抗血小板治疗的方案及时长, objectType=article, longId=736139, objectId=40fbe3613916, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40fbe3613916, replyNumber=0, likeNumber=47, createdTime=2023-02-07, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40fbe3613916, moduleTitle=JACC：经皮冠状动脉介入治疗术后抗血小板治疗的方案及时长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40fbe3613916)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648963, encodeId=f8461648963a3, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=BJH：经皮冠状动脉介入治疗后血小板反应性高的患者的强化抗血小板治疗——抗血栓药物的更佳管理 (OPTIMA)-2试验, objectType=article, longId=218247, objectId=4e9a21824e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e9a21824e71, replyNumber=0, likeNumber=39, createdTime=2022-03-06, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e9a21824e71, moduleTitle=BJH：经皮冠状动脉介入治疗后血小板反应性高的患者的强化抗血小板治疗——抗血栓药物的更佳管理 (OPTIMA)-2试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e9a21824e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648962, encodeId=99f3164896233, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Eur Heart J：经皮冠状动脉介入治疗的慢性肾脏病患者替格瑞洛单药治疗效果如何？, objectType=article, longId=216217, objectId=7a6e21621ef1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a6e21621ef1, replyNumber=0, likeNumber=45, createdTime=2022-02-19, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a6e21621ef1, moduleTitle=Eur Heart J：经皮冠状动脉介入治疗的慢性肾脏病患者替格瑞洛单药治疗效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a6e21621ef1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648966, encodeId=87c41648966b7, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=CARDIOVASC DIABETOL：糖化白蛋白（GA）对NSTE-ACS患者经皮冠状动脉介入治疗的预后意义, objectType=article, longId=294887, objectId=586429488eba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=586429488eba, replyNumber=0, likeNumber=49, createdTime=2022-05-01, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=586429488eba, moduleTitle=CARDIOVASC DIABETOL：糖化白蛋白（GA）对NSTE-ACS患者经皮冠状动脉介入治疗的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=586429488eba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648967, encodeId=d76e164896ec9, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=JAHA：二十碳五烯乙酯治疗以减少既往经皮冠状动脉介入治疗患者的缺血事件, objectType=article, longId=300559, objectId=54e5300559ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54e5300559ac, replyNumber=0, likeNumber=54, createdTime=2022-07-09, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54e5300559ac, moduleTitle=JAHA：二十碳五烯乙酯治疗以减少既往经皮冠状动脉介入治疗患者的缺血事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54e5300559ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648964, encodeId=8c331648964a5, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Cardiovasc Diabetol：不同胰岛素抵抗替代指标对2型糖尿病患者经皮冠状动脉介入治疗后预后预测和分层的比较, objectType=article, longId=218500, objectId=c17321850023, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c17321850023, replyNumber=0, likeNumber=33, createdTime=2022-03-30, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c17321850023, moduleTitle=Cardiovasc Diabetol：不同胰岛素抵抗替代指标对2型糖尿病患者经皮冠状动脉介入治疗后预后预测和分层的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c17321850023)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648965, encodeId=27aa164896599, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Lancet：经皮冠状动脉介入治疗发生造影剂相关急性肾损伤的风险评估, objectType=article, longId=220555, objectId=d9cb22055556, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9cb22055556, replyNumber=0, likeNumber=41, createdTime=2022-03-01, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9cb22055556, moduleTitle=Lancet：经皮冠状动脉介入治疗发生造影剂相关急性肾损伤的风险评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9cb22055556)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648959, encodeId=229416489593b, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Circulation：经皮冠状动脉介入治疗置入药物洗脱支架后的双重抗血小板治疗时间, objectType=article, longId=198826, objectId=d8a019882604, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8a019882604, replyNumber=0, likeNumber=51, createdTime=2021-04-03, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8a019882604, moduleTitle=Circulation：经皮冠状动脉介入治疗置入药物洗脱支架后的双重抗血小板治疗时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8a019882604)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648961, encodeId=60bf1648961b2, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Eur Heart J：经皮冠状动脉介入治疗的癌症患者90天内因急性心肌梗塞和出血再入院分析, objectType=article, longId=207919, objectId=222f20e919fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=222f20e919fa, replyNumber=0, likeNumber=43, createdTime=2021-06-03, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=222f20e919fa, moduleTitle=Eur Heart J：经皮冠状动脉介入治疗的癌症患者90天内因急性心肌梗塞和出血再入院分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=222f20e919fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648960, encodeId=7b0b1648960cf, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Heart：β受体阻滞剂在经皮冠状动脉介入治疗急性冠脉综合征患者中的作用, objectType=article, longId=200304, objectId=58642003043d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58642003043d, replyNumber=0, likeNumber=41, createdTime=2021-05-11, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58642003043d, moduleTitle=Heart：β受体阻滞剂在经皮冠状动脉介入治疗急性冠脉综合征患者中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58642003043d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648956, encodeId=1cb7164895650, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Circulation：Impella在采用机械循环支持的经皮冠状动脉介入治疗患者中的使用、临床预后和费用在近20年来的变化趋势, objectType=article, longId=187112, objectId=2e9d18e11225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e9d18e11225, replyNumber=0, likeNumber=31, createdTime=2020-09-18, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e9d18e11225, moduleTitle=Circulation：Impella在采用机械循环支持的经皮冠状动脉介入治疗患者中的使用、临床预后和费用在近20年来的变化趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e9d18e11225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648958, encodeId=da5b1648958c0, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Ann Intern Med：经皮冠状动脉介入治疗后房颤双联和三联治疗效果比较, objectType=article, longId=190318, objectId=173719031898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=173719031898, replyNumber=0, likeNumber=34, createdTime=2020-06-17, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=173719031898, moduleTitle=Ann Intern Med：经皮冠状动脉介入治疗后房颤双联和三联治疗效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=173719031898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648954, encodeId=d2fc1648954ad, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Lancet：三支或左主干病变患者经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较, objectType=article, longId=178759, objectId=d8561e8759a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8561e8759a0, replyNumber=0, likeNumber=40, createdTime=2020-04-06, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8561e8759a0, moduleTitle=Lancet：三支或左主干病变患者经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8561e8759a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648957, encodeId=ec79164895ee2, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Heart：经皮冠状动脉介入治疗的急性心肌梗死患者年龄与再入院之间的相关性, objectType=article, longId=189603, objectId=76c5189603c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76c5189603c3, replyNumber=0, likeNumber=40, createdTime=2020-11-07, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76c5189603c3, moduleTitle=Heart：经皮冠状动脉介入治疗的急性心肌梗死患者年龄与再入院之间的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76c5189603c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648955, encodeId=7a581648955f9, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Circulation：经皮冠状动脉介入治疗重度主动脉瓣狭窄和冠状动脉疾病, objectType=article, longId=181826, objectId=e7071818261a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7071818261a, replyNumber=0, likeNumber=41, createdTime=2020-06-05, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7071818261a, moduleTitle=Circulation：经皮冠状动脉介入治疗重度主动脉瓣狭窄和冠状动脉疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7071818261a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648952, encodeId=2a4b1648952d4, content=<a href='/topic/show?id=6e0630843d0' target=_blank style='color:#2F92EE;'>#冠状动脉介入治疗#</a>, objectTitle=Clinica Chimica Acta：经皮冠状动脉介入治疗急性ST段抬高性心肌梗死患者术前纤维蛋白原-白蛋白比值对死亡率的影响, objectType=article, longId=177032, objectId=f7671e7032ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7671e7032ba, replyNumber=0, likeNumber=30, createdTime=2019-12-30, rootId=0, userName=3631181, userId=a9ec23698107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7671e7032ba, moduleTitle=Clinica Chimica Acta：经皮冠状动脉介入治疗急性ST段抬高性心肌梗死患者术前纤维蛋白原-白蛋白比值对死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7671e7032ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

冠状动脉介入治疗

2020-05-29

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Cardiovasc Diabetol：甘油三酯-葡萄糖指数和剩余SYNTAX评分在预测接受经皮冠状动脉介入治疗的2型糖尿病患者中期主要心脏不良事件中的协同作用

2023-04-30

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良

2022-11-12

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Heart：血小板计数对经皮冠状动脉介入治疗患者的意义

2022-11-02

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Cardiovasc Diabetol：2型糖尿病病患者高纤维蛋白原/白蛋白比与经皮冠状动脉介入治疗患者预后不良相关

2022-05-31

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

JACC：经皮冠状动脉介入治疗术后抗血小板治疗的方案及时长

2023-02-07

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

BJH：经皮冠状动脉介入治疗后血小板反应性高的患者的强化抗血小板治疗——抗血栓药物的更佳管理 (OPTIMA)-2试验

2022-03-06

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Eur Heart J：经皮冠状动脉介入治疗的慢性肾脏病患者替格瑞洛单药治疗效果如何？

2022-02-19

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

CARDIOVASC DIABETOL：糖化白蛋白（GA）对NSTE-ACS患者经皮冠状动脉介入治疗的预后意义

2022-05-01

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

JAHA：二十碳五烯乙酯治疗以减少既往经皮冠状动脉介入治疗患者的缺血事件

2022-07-09

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Cardiovasc Diabetol：不同胰岛素抵抗替代指标对2型糖尿病患者经皮冠状动脉介入治疗后预后预测和分层的比较

2022-03-30

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Lancet：经皮冠状动脉介入治疗发生造影剂相关急性肾损伤的风险评估

2022-03-01

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Circulation：经皮冠状动脉介入治疗置入药物洗脱支架后的双重抗血小板治疗时间

2021-04-03

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Eur Heart J：经皮冠状动脉介入治疗的癌症患者90天内因急性心肌梗塞和出血再入院分析

2021-06-03

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Heart：β受体阻滞剂在经皮冠状动脉介入治疗急性冠脉综合征患者中的作用

2021-05-11

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Circulation：Impella在采用机械循环支持的经皮冠状动脉介入治疗患者中的使用、临床预后和费用在近20年来的变化趋势

2020-09-18

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Ann Intern Med：经皮冠状动脉介入治疗后房颤双联和三联治疗效果比较

2020-06-17

仁医06 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Lancet：三支或左主干病变患者经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较

2020-04-06

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Heart：经皮冠状动脉介入治疗的急性心肌梗死患者年龄与再入院之间的相关性

2020-11-07

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Circulation：经皮冠状动脉介入治疗重度主动脉瓣狭窄和冠状动脉疾病

2020-06-05

3631181 (审核中...)

前往app查看评论内容

#冠状动脉介入治疗#

Clinica Chimica Acta：经皮冠状动脉介入治疗急性ST段抬高性心肌梗死患者术前纤维蛋白原-白蛋白比值对死亡率的影响

2019-12-30

科室
- - 订阅+
  - 更多科室
工具
服务